Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5202132
Max Phase: Preclinical
Molecular Formula: C19H17FN2O5S
Molecular Weight: 404.42
Associated Items:
ID: ALA5202132
Max Phase: Preclinical
Molecular Formula: C19H17FN2O5S
Molecular Weight: 404.42
Associated Items:
Canonical SMILES: Cc1ccc(F)cc1N(C)C(=O)c1ccc(-c2ccc(OS(N)(=O)=O)cc2)o1
Standard InChI: InChI=1S/C19H17FN2O5S/c1-12-3-6-14(20)11-16(12)22(2)19(23)18-10-9-17(26-18)13-4-7-15(8-5-13)27-28(21,24)25/h3-11H,1-2H3,(H2,21,24,25)
Standard InChI Key: HSBFOIKRCUCYNZ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 404.42 | Molecular Weight (Monoisotopic): 404.0842 | AlogP: 3.25 | #Rotatable Bonds: 5 |
Polar Surface Area: 102.84 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.71 | CX Basic pKa: | CX LogP: 2.86 | CX LogD: 2.86 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.70 | Np Likeness Score: -1.43 |
1. Mohamed A, Salah M, Tahoun M, Hawner M, Abdelsamie AS, Frotscher M.. (2022) Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis., 65 (17.0): [PMID:35993890] [10.1021/acs.jmedchem.2c00589] |
Source(1):